Keros Therapeutics Inc (KROS)
11.20 x 10 11.59 x 13
Post-market by (Cboe BZX)
11.35 -0.27 (-2.32%) 03/18/25 [NASDAQ]
11.20 x 10 11.59 x 13
Post-market 11.35 unch (unch) 16:02 ET
for Tue, Mar 18th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 7,020 | N/A | N/A |
| Other current assets | 1,526 | 0 | 0 |
| TOTAL | $8,927 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 708 | N/A | N/A |
| Other Non-Current Assets | 1,320 | 0 | 0 |
| TOTAL | $2,028 | $N/A | $N/A |
| Total Assets | $10,955 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 2,088 | 0 | 0 |
| Accrued Expenses | 2,022 | N/A | N/A |
| TOTAL | $4,486 | $N/A | $N/A |
| Non-Current Liabilities | |||
| aiOther Non-Current Liabilities | 5,974 | 0 | 0 |
| TOTAL | $5,974 | $N/A | $N/A |
| Total Liabilities | $10,460 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 1 | N/A | N/A |
| Retained earnings | -19,650 | N/A | N/A |
| Other shareholders' equity | 19,941 | 0 | 0 |
| TOTAL | $495 | $N/A | $N/A |
| Total Liabilities And Equity | $10,955 | $0 | $0 |